Cargando…
Palmoplantar Pustulosis-like Eruption Induced by Baricitinib for Treatment of Rheumatoid Arthritis
OBJECTIVES: Baricitinib is an orally active Janus kinase (JAK) inhibitor used in the treatment of moderate to severe rheumatoid arthritis (RA). MATERIALS AND METHODS: Here, we report the case of a 56-year-old Caucasian male diagnosed with RA who developed palmoplantar pustulosis (PPP) while being tr...
Autores principales: | Koumaki, Dimitra, Koumaki, Vasiliki, Lagoudaki, Eleni, Bertsias, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993915/ https://www.ncbi.nlm.nih.gov/pubmed/32015973 http://dx.doi.org/10.12890/2019_001383 |
Ejemplares similares
-
Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
por: Shibata, Tomoyuki, et al.
Publicado: (2019) -
Turicella otitidis as an Unusual Agent Causing Palmoplantar Eczema: An Emerging Pathogen
por: Koumaki, Dimitra, et al.
Publicado: (2020) -
Panitumumab-Induced Eruptive Seborrhoeic Keratosis in a Patient with Metastatic Colorectal Cancer
por: Koumaki, Dimitra, et al.
Publicado: (2020) -
Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis
por: Haller, Christoph, et al.
Publicado: (2021) -
Pruritic annular and vesicular eruption on trunk and extremities
por: Koumaki, Dimitra, et al.
Publicado: (2020)